Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The complexity of Alzheimer’s disease: an evolving puzzle
Camilla Ferrari, Sandro Sorbi
Physiological Reviews (2021) Vol. 101, Iss. 3, pp. 1047-1081
Closed Access | Times Cited: 207

Showing 1-25 of 207 citing articles:

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Chenghuan Song, Jiyun Shi, Pingao Zhang, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 166
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135
Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model
Qian Shi, Cheng Chang, Afaf Saliba, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 27, pp. 5294-5313
Open Access | Times Cited: 75
The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia
Emma Nichols, Richard L. Merrick, Simon I Hay, et al.
The Lancet Healthy Longevity (2023) Vol. 4, Iss. 3, pp. e115-e125
Open Access | Times Cited: 46
Damage to endothelial barriers and its contribution to long COVID
Xiaoming Wu, Mengqi Xiang, Haijiao Jing, et al.
Angiogenesis (2023) Vol. 27, Iss. 1, pp. 5-22
Open Access | Times Cited: 45
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 21
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 86
Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
Mateo Rodríguez-Giraldo, Rodrigo E. González-Reyes, Sofía Ramírez-Guerrero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13630-13630
Open Access | Times Cited: 64
Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress
Víctor Valverde-Salazar, Daniel Ruiz-Gabarre, Vega García‐Escudero
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 31
An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes
Katrin Colleselli, Anna Stierschneider, Christoph Wiesner
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12464-12464
Open Access | Times Cited: 24
Hyperoside alleviates toxicity of β-amyloid via endoplasmic reticulum-mitochondrial calcium signal transduction cascade in APP/PS1 double transgenic Alzheimer's disease mice
Linlin Song, Yuan Qu, Yong Tang, et al.
Redox Biology (2023) Vol. 61, pp. 102637-102637
Open Access | Times Cited: 23
Source space connectomics of neurodegeneration: One-metric approach does not fit all
Pavel Prado, Sebastián Moguilner, Jhony Mejia, et al.
Neurobiology of Disease (2023) Vol. 179, pp. 106047-106047
Open Access | Times Cited: 23
Ghrelin Induces Ferroptosis Resistance and M2 Polarization of Microglia to Alleviate Neuroinflammation and Cognitive Impairment in Alzheimer’s Disease
Yaoxue Guo, Junli Zhao, Yizhi Liu, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access | Times Cited: 1
The impact of genetic variability on Alzheimer’s therapies: obstacles for pharmacogenetic progress
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025), pp. 1-28
Closed Access | Times Cited: 1
Brain Microenvironment-Remodeling Nanomedicine Improves Cerebral Glucose Metabolism, Mitochondrial Activity and Synaptic Function in A Mouse Model of Alzheimer’s Disease
Elliya Park, Chunsheng He, Azhar Z. Abbasi, et al.
Biomaterials (2025), pp. 123142-123142
Open Access | Times Cited: 1
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Eun Sun Jung, Hayoung Choi, Inhee Mook‐Jung
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Does voice matter? Investigating patient satisfaction on mobile health consultation
Yixuan Liu, Xiaofei Zhang, Libo Liu, et al.
Information Processing & Management (2023) Vol. 60, Iss. 4, pp. 103362-103362
Closed Access | Times Cited: 22
Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer’s Disease from 2004 to 2022
Rui Wang, Yi Zhu, Lanfang Qin, et al.
Dementia and Geriatric Cognitive Disorders (2023) Vol. 52, Iss. 2, pp. 47-73
Closed Access | Times Cited: 20
Mechanosensitive Piezo1 channel in physiology and pathophysiology of the central nervous system
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102026-102026
Open Access | Times Cited: 18
A detection model of cognitive impairment via the integrated gait and eye movement analysis from a large Chinese community cohort
Jingyi Lin, Tianyan Xu, Xuan Yang, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 2, pp. 1089-1101
Open Access | Times Cited: 18
Animal models of Alzheimer’s disease: preclinical insights and challenges
Qingqing Xu, Wen Yang, Mei Zhong, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 17
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Guowang Cheng, Aihua Xie, Zhao Yan, et al.
Brain‐X (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 17
The Role of Reactive Oxygen Species in Alzheimer's Disease:from Mechanism to Biomaterials Therapy
Zhuohang Yu, Feng Luo
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Closed Access | Times Cited: 8
Advanced Nano Delivery System for Stem Cell Therapy for Alzheimer's Disease
Yilong Pan, Long Li, Ning Cao, et al.
Biomaterials (2024) Vol. 314, pp. 122852-122852
Closed Access | Times Cited: 8
MSC-Derived Extracellular Vesicles Alleviate NLRP3/GSDMD-Mediated Neuroinflammation in Mouse Model of Sporadic Alzheimer’s Disease
Lishan Lin, Long‐Xin Huang, Sen Huang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5494-5509
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top